Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.51 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.51 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.51 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | NAMPT | P43490 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL9639241 | 0.98 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| Benzo[D]Thiazole SCHEMBL2404928 | 0.92 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| Sulfuric Acid SCHEMBL28605250 | 0.92 | CA2 (0.49) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| SCHEMBL29517954 | 0.86 | TXNRD1 (0.51) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| SCHEMBL1011755 | 0.86 | TXNRD1 (0.51) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| SCHEMBL31106335 | 0.84 | TXNRD1 (0.50) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| SCHEMBL27980421 | 0.83 | POLB (0.50) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| SCHEMBL15688963 | 0.83 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| SCHEMBL30655029 | 0.83 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CYP3A4TDP1HTT | |
| SCHEMBL11890646 | 0.78 | MAPT (0.60) | ALDH1A1TDP1HTTKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120166857-A | Photoelectric device, preparation method thereof and display device | TCL科技集团股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-117658944-A | Preparation method of 6-nitrobenzothiazole | 安徽科芯微流化工科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-112326628-B | Preparation of ratio-type SERS detection platform based on self-assembly aggregation | 济南大学 | 2022-09-16 | — | — | CN | claimed |
| CN-112326628-A | Preparation of ratio-type SERS detection platform based on self-assembly aggregation | 济南大学 | 2021-02-05 | — | — | CN | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| US-4889796-A | CONTAINING BENZOXAZOLE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-26 | — | — | US | claimed |
| JP-2055749-A | — | — | None | — | — | JP | disclosed |
| US-12622896-B2 | Antiviral compounds, compositions and methods of use | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-05-12 | — | — | US | disclosed |
| US-12435054-B2 | Therapeutic compounds and methods of use | GENENTECH, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| CN-120166857-A | Photoelectric device, preparation method thereof and display device | TCL科技集团股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| US-20250171464-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2025-05-29 | — | — | US | disclosed |
| US-3988154-A | Photographic supports and elements utilizing photobleachable omicron-nitroarylidene dyes | EASTMAN KODAK COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
| US-3988156-A | Photographic supports and elements utilizing photobleachable o-nitroarylidene dyes | EASTMAN KODAK COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
| US-3984248-A | Photographic polymeric film supports containing photobleachable o-nitroarylidene dyes | EASTMAN KODAK COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
| US-3955996-A | Method for spectrally sensitizing photographic light-sensitive emulsion | FUJI PHOTO FILM CO., LTD. (JA) | 1976-05-11 | — | — | US | disclosed |
| US-3945832-A | Fogged, direct-positive silver halide emulsion containing desensitizers and a dimethine optical sensitizing dye | FUJI PHOTO FILM CO., LTD. (JA) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171464-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE | VHL, TP53, MCL1 | ALDH1A1 829/4885SMN1; SMN2 335/4885CYP3A4 2755/4885 |
| US-12435054-B2 | Therapeutic compounds and methods of use | VHL, NQO1, PCSK9 | ALDH1A1 547/4885SMN1; SMN2 756/4885CYP3A4 1567/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | ALDH1A1 4757/4885SMN1; SMN2 4265/4885CYP3A4 447/4885 |
| US-12622896-B2 | Antiviral compounds, compositions and methods of use | SARS1, NSUN2, ZC3HAV1 | ALDH1A1 4172/4885SMN1; SMN2 1838/4885CYP3A4 818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.